NASDAQ:MTFB - MOTIF BIO PLC/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MOTIF BIO PLC/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.10 0.00 (0.00 %) (As of 12/16/2019) Add Compare Today's Range$0.10Now: $0.11▼$0.1250-Day Range$0.11MA: $0.11▼$0.1152-Week Range$0.08Now: $0.11▼$11.50Volume867,698 shsAverage VolumeN/AMarket Capitalization$1.56 millionP/E RatioN/ADividend YieldN/ABeta-0.32 ProfileAnalyst RatingsAdvanced ChartFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MTFB Previous Symbol CUSIPN/A CIK1674657 Webhttp://www.motifbio.com/ Phone212-210-6248Debt Debt-to-Equity RatioN/A Current Ratio0.26 Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.60) per share Price / Book-0.18Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees7 Outstanding Shares14,830,000Market Cap$1.56 million Next Earnings Date4/20/2020 (Estimated) OptionableNot Optionable Receive MTFB News and Ratings via Email Sign-up to receive the latest news and ratings for MTFB and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:MTFB Rates by TradingView MOTIF BIO PLC/S (NASDAQ:MTFB) Frequently Asked Questions What is MOTIF BIO PLC/S's stock symbol? MOTIF BIO PLC/S trades on the NASDAQ under the ticker symbol "MTFB." When is MOTIF BIO PLC/S's next earnings date? MOTIF BIO PLC/S is scheduled to release their next quarterly earnings announcement on Monday, April 20th 2020. View Earnings Estimates for MOTIF BIO PLC/S. What price target have analysts set for MTFB? 2 equities research analysts have issued 12 month price targets for MOTIF BIO PLC/S's stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate MOTIF BIO PLC/S's share price to reach $5.00 in the next twelve months. This suggests a possible upside of 4,661.9% from the stock's current price. View Analyst Price Targets for MOTIF BIO PLC/S. What is the consensus analysts' recommendation for MOTIF BIO PLC/S? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MOTIF BIO PLC/S in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for MOTIF BIO PLC/S. What are Wall Street analysts saying about MOTIF BIO PLC/S stock? Here are some recent quotes from research analysts about MOTIF BIO PLC/S stock: 1. According to Zacks Investment Research, "Motif Bio plc is a biopharmaceutical company. It engaged in the research and development of antibiotics for serious and life-threatening infections caused by multi-drug resistant bacteria. The company's product pipeline includes Iclaprim, REVIVE-1 and REVIVE-2 which are in clinical stage. Motif Bio plc is headquartered in London, UK. " (8/8/2019) 2. Northland Securities analysts commented, "We anticipate the Co. to provide guidance on iclaprim’s path forward in June. Key Points Motif Completes $3.55MM Raise: Pre-open, Motif announced that it has completed placement of 45MM ordinary shares priced at 6 pence, raising gross proceeds of £2.7MM (~$3.55MM USD) providing the Company with additional working capital. The offering, if translated into ADS equivalents, would approximate 2.5MM ADS shares at $1.58 per share. Through FDA Update: The net proceeds from the offering, combined with existing cash resources, and adjusted for repayment of $0.5MM to Hercules Capital, approximate $5- $5.5MM. We anticipate cash balances to be sufficient to fund operations beyond its receipt of minutes anticipated in early-June from the May 3rd Type A meeting with the FDA." (3/26/2019) Has MOTIF BIO PLC/S been receiving favorable news coverage? News stories about MTFB stock have been trending neutral this week, InfoTrie reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. MOTIF BIO PLC/S earned a daily sentiment score of 0.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for MOTIF BIO PLC/S. Who are some of MOTIF BIO PLC/S's key competitors? Some companies that are related to MOTIF BIO PLC/S include GT Biopharma (GTBP), Capricor Therapeutics (CAPR), Earth Science Tech (ETST), Praxsyn (PXYN), Xenetic Biosciences (XBIO), Salarius Pharmaceuticals (SLRX), Sienna Biopharmaceuticals (SNNA), Innovus Pharmaceuticals (INNV), Tonix Pharmaceuticals (TNXP), IntelliPharmaCeutics Intl (IPCIF), Wellness Center USA (WCUI), MusclePharm (MSLP), Innovus Pharmaceuticals (INNVD), Auris Medical (EARS) and Boston Therapeutics (BTHE). What other stocks do shareholders of MOTIF BIO PLC/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other MOTIF BIO PLC/S investors own include Sorrento Therapeutics (SRNE), Neurocrine Biosciences (NBIX), Allergan (AGN), Ampliphi Biosciences (APHB), SDX Energy (SDX), Forward Pharma A/S (FWP), Canopy Growth (CGC), Novartis (NVS), Adaptimmune Therapeutics (ADAP) and Allena Pharmaceuticals (ALNA). Who are MOTIF BIO PLC/S's key executives? MOTIF BIO PLC/S's management team includes the folowing people: Dr. Graham George Lumsden, CEO & Exec. Director (Age 59)Mr. Jonathan E. Gold, CFO & Exec. Director (Age 46)Dr. David B. Huang, Chief Medical Officer (Age 44)Mr. Robert Dickey IV, Advisor (Age 63)Laurie Doyle, Head of Investor Relations & Corp. Communications When did MOTIF BIO PLC/S IPO? (MTFB) raised $17 million in an initial public offering on Friday, November 18th 2016. The company issued 2,400,000 shares at a price of $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO. How do I buy shares of MOTIF BIO PLC/S? Shares of MTFB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is MOTIF BIO PLC/S's stock price today? One share of MTFB stock can currently be purchased for approximately $0.11. How big of a company is MOTIF BIO PLC/S? MOTIF BIO PLC/S has a market capitalization of $1.56 million. The company earns $-13,980,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. MOTIF BIO PLC/S employs 7 workers across the globe.View Additional Information About MOTIF BIO PLC/S. What is MOTIF BIO PLC/S's official website? The official website for MOTIF BIO PLC/S is http://www.motifbio.com/. How can I contact MOTIF BIO PLC/S? MOTIF BIO PLC/S's mailing address is 201 TEMPLE CHAMBERS 3-7 TEMPLE AVENUE, LONDON X0, EC4Y0DT. The company can be reached via phone at 212-210-6248 or via email at [email protected] MarketBeat Community Rating for MOTIF BIO PLC/S (NASDAQ MTFB)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 233 (Thanks for Voting!)Underperform Votes: 268 (Thanks for Voting!)Total Votes: 501MarketBeat's community ratings are surveys of what our community members think about MOTIF BIO PLC/S and other stocks. Vote "Outperform" if you believe MTFB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/25/2020 by MarketBeat.com StaffFeatured Article: What does the Dogs of the Dow mean?
